Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia
Study Evaluating the Association of CAG Repeat Polymorphisms and Finasteride Response in Women With Androgenetic Alopecia
In the register
The register attaches this trial to Finasteride (Propecia) (Organon), currently at “Approved” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Completed
- Declared phase
- Phase 1
- Sponsor
- HairDx, LLC
- Participants (registry)
- 12
- Start
- December 2008
- Primary completion
- December 2009
- Study completion
- December 2009
- Last registry update
- January 2010
- Countries
- —
Conditions studied: Androgenetic Alopecia
Interventions: Finasteride
Other trials of Finasteride (Propecia)
Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia
Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.